The Manufacturers Life Insurance Company Acquires 155,192 Shares of Envista Holdings Co. (NYSE:NVST)

The Manufacturers Life Insurance Company grew its holdings in Envista Holdings Co. (NYSE:NVSTFree Report) by 20.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 905,317 shares of the company’s stock after buying an additional 155,192 shares during the quarter. The Manufacturers Life Insurance Company owned approximately 0.53% of Envista worth $21,782,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the business. Headinvest LLC acquired a new position in shares of Envista during the third quarter valued at $28,000. Fifth Third Bancorp raised its holdings in Envista by 98.1% in the fourth quarter. Fifth Third Bancorp now owns 1,254 shares of the company’s stock worth $30,000 after purchasing an additional 621 shares during the period. Itau Unibanco Holding S.A. bought a new position in shares of Envista during the third quarter worth $47,000. Covestor Ltd grew its holdings in shares of Envista by 33.9% in the 3rd quarter. Covestor Ltd now owns 2,462 shares of the company’s stock valued at $69,000 after buying an additional 624 shares during the period. Finally, Signaturefd LLC increased its position in shares of Envista by 1,297.9% in the 4th quarter. Signaturefd LLC now owns 2,614 shares of the company’s stock valued at $63,000 after buying an additional 2,427 shares in the last quarter.

Envista Price Performance

Shares of NYSE NVST opened at $18.25 on Friday. The business has a 50-day moving average of $19.35 and a 200-day moving average of $21.74. Envista Holdings Co. has a fifty-two week low of $17.64 and a fifty-two week high of $36.14. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.27 and a quick ratio of 1.93. The stock has a market capitalization of $3.14 billion, a price-to-earnings ratio of -25.35, a PEG ratio of 15.01 and a beta of 1.34.

Envista (NYSE:NVSTGet Free Report) last released its quarterly earnings data on Wednesday, May 1st. The company reported $0.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.31 by ($0.05). The business had revenue of $623.60 million during the quarter, compared to the consensus estimate of $634.85 million. Envista had a negative net margin of 4.70% and a positive return on equity of 5.84%. Envista’s quarterly revenue was down .6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.38 EPS. As a group, sell-side analysts predict that Envista Holdings Co. will post 1.23 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the company. JPMorgan Chase & Co. decreased their target price on Envista from $29.00 to $23.00 and set an “overweight” rating for the company in a research note on Thursday, May 2nd. Needham & Company LLC restated a “hold” rating on shares of Envista in a report on Monday, June 3rd. Robert W. Baird reduced their price target on shares of Envista from $22.00 to $19.00 and set a “neutral” rating for the company in a report on Thursday, May 2nd. The Goldman Sachs Group dropped their price objective on shares of Envista from $20.00 to $17.50 and set a “sell” rating on the stock in a report on Friday, May 3rd. Finally, SVB Leerink initiated coverage on shares of Envista in a research note on Monday, February 26th. They issued an “underperform” rating and a $19.00 target price for the company. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Envista has an average rating of “Hold” and an average target price of $25.86.

Check Out Our Latest Stock Analysis on NVST

About Envista

(Free Report)

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

Featured Articles

Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVSTFree Report).

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.